Global Consolidation Hits Indian Contract Drug Manufacturing Companies

February 18, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Econmic Times -- Mergers & acquisitions in the global pharmaceutical industry that have led to reduction in outsourced research work have hit Indian contract drug manufacturing and research services or CRAMS companies.

Twitter
LinkedIn
Facebook
Email
Print

Job creations Asia